Abingdon Health Plc (AIM: ABDX)

Market Cap	30.81M
Revenue (ttm)	6.14M
Net Income (ttm)	-1.27M
Shares Out	385.16M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	257,458
Average Volume	150,118
Open	8.50
Previous Close	8.00
Day's Range	7.36 - 8.50
52-Week Range	6.50 - 11.75
Beta	0.18
RSI	71.83
Earnings Date	Mar 14, 2025

About Abingdon Health

Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and for nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2008
• Employees: 84
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ABDX

Financial Performance

In 2024, Abingdon Health's revenue was 6.14 million, an increase of 51.67% compared to the previous year's 4.05 million. Losses were -1.27 million, -63.36% less than in 2023.